Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $322.37 | $47.34 | 581.03% | 1,611.85x | 95.16x | 6.58x | 8.21x | 2.62x | $941.74M | 2.68% | $4.36B | 40.00 | $33.25B | 53.91 | ||
| NVO | NOVO NORDISK A S | $37.62 | $152.55 | -75.34% | 10.31x | 1.65x | 3.43x | 5.47x | 0.11x | $9.33B | 5.55% | $30.70B | 6.88 | $184.51B | 7.65 | ||
| CORT | CORCEPT THERAPEUTICS INC | $35.78 | $41.69 | -14.17% | 37.66x | 57.82x | 4.88x | 5.88x | 0.37x | $141.79M | 3.81% | $647.81M | 6.24 | $3.69B | 81.66 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $9.09 | $16.80 | -45.91% | 18.94x | 16.06x | 6.03x | 3.84x | 0.24x | -$23.64M | -4.65% | $133.17M | 2.38 | $520.02M | 7.74 | ||
| SLNO | SOLENO THERAPEUTICS INC | $38.09 | $120.63 | -68.42% | 95.23x | 8.87x | 10.17x | 4.37x | 0.12x | $46.73M | 2.41% | $450.12M | 8.86 | $1.95B | 67.22 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $331.24 | $109.32 | 203.01% | 138.59x | 49.45x | 11.68x | 55.67x | 1.30x | $465.38M | 1.07% | $789.18M | 6.02 | $45.24B | 71.65 | ||
| ADMA | ADMA BIOLOGICS INC | $15.18 | $12.74 | 19.13% | 24.48x | 16.63x | 7.09x | 7.57x | 0.63x | $27.82M | 0.77% | $477.32M | 2.00 | $3.60B | 18.20 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $43.49 | $21.29 | 104.25% | 54.36x | 27.26x | 4.76x | 5.86x | 0.98x | $136.42M | 4.23% | $567.61M | 7.65 | $3.17B | 33.72 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $196.17 | $73.93 | 165.33% | 84.92x | 23.19x | 15.29x | 4.06x | 1.22x | $30.76M | 0.80% | $950.17M | 48.53 | $4.17B | 40.51 | ||
| HALO | HALOZYME THERAPEUTICS INC | $69.22 | $74.12 | -6.61% | 26.22x | 8.31x | 5.94x | 167.35x | 0.44x | $644.59M | 7.77% | $48.81M | 0.41 | $10.18B | 17.76 | ||
| KRYS | KRYSTAL BIOTECH INC | $276.36 | $121.87 | 126.76% | 39.03x | 33.18x | 20.56x | 6.62x | 1.29x | $189.35M | 2.37% | $1.22B | 42.14 | $7.59B | 38.73 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $3.01 | $3.66 | -17.65% | 43.00x | 17.02x | 3.86x | 4.58x | 0.35x | -$11.69M | -4.88% | $52.91M | 0.67 | $236.60M | 26.67 | ||
| RPRX | ROYALTY PHARMA PLC | $45.36 | $48.22 | -5.93% | 25.34x | 8.75x | 8.20x | 2.69x | 0.45x | $2.22B | 11.38% | $9.71B | 22.60 | $34.50B | 31.98 | ||
| TECH | BIO-TECHNE CORP | $57.92 | $16.82 | 244.34% | 111.38x | 28.67x | 7.43x | 4.51x | 1.58x | $223.02M | 2.47% | $2.01B | 12.90 | $9.24B | 40.81 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $21.64 | $5.45 | 296.95% | 120.22x | -18.83x | 2.72x | 7.47x | 1.85x | $45.01M | 1.65% | $370.15M | 2.93 | $2.77B | 39.61 | ||
| VCEL | VERICEL CORP | $37.68 | $10.67 | 253.17% | 114.18x | 66.48x | 6.87x | 5.39x | 1.62x | $24.75M | 1.31% | $354.64M | 7.05 | $1.91B | 54.70 | ||
| ABEO | ABEONA THERAPEUTICS INC | $5.20 | $19.55 | -73.40% | 3.27x | -96.47x | 742.86x | 1.65x | 0.19x | -$82.36M | -29.19% | $171.23M | 3.16 | $222.68M | 2.48 | ||
| GMAB | GENMAB A | $29.24 | $106.52 | -72.55% | 18.86x | 1.73x | 5.05x | 3.21x | 0.11x | $1.13B | 6.02% | $5.85B | 9.10 | $22.49B | 14.57 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $29.05 | $63.03 | -53.91% | 10.53x | 6.72x | 1.92x | 1.93x | 0.23x | $347.89M | 20.83% | $870.22M | 15.14 | $1.09B | 4.28 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $61.11 | $48.39 | 26.28% | 33.58x | 13.78x | 3.64x | 1.93x | 0.61x | $724.96M | 6.19% | $6.09B | 31.74 | $11.04B | 19.27 | ||
| MNKD | MANNKIND CORP | $3.24 | $1.47 | 119.76% | 162.00x | 37.11x | 2.84x | -19.56x | 0.90x | $13.69M | 1.39% | -$51.02M | -0.17 | $1.53B | 28.87 | ||
| XOMA | XOMA ROYALTY CORP | $26.76 | $16.21 | 65.10% | 33.04x | 85.11x | 6.90x | 3.77x | 0.88x | -$12.41M | -3.82% | $87.94M | 7.25 | $372.81M | 13.94 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $5.18 | $4.42 | 17.15% | 19.19x | 17.22x | 3.31x | 5.85x | 0.69x | $21.15M | 5.12% | $70.68M | 0.89 | $352.16M | 15.52 | ||
| ARGX | ARGENX SE | $771.53 | $378.62 | 103.77% | 31.11x | 25.73x | N/A | 5.49x | 1.24x | $798.86M | 1.69% | $8.62B | 140.56 | $43.24B | 28.04 | ||
| CRMD | CORMEDIX INC | $7.35 | $14.87 | -50.57% | 3.24x | 4.52x | 2.60x | 1.55x | 1.81x | $74.42M | 13.33% | $374.13M | 4.93 | $679.53M | 6.05 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $24.88 | $24.09 | 3.26% | 14.22x | 13.70x | 5.17x | 3.18x | 0.68x | $208.61M | 6.86% | $954.27M | 7.80 | $2.33B | 7.25 | ||
| VCYT | VERACYTE INC | $38.75 | $15.22 | 154.59% | 46.13x | 34.29x | 5.89x | 2.35x | 1.41x | $126.63M | 4.16% | $1.31B | 16.67 | $2.75B | 29.74 | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $24.64 | $12.46 | 97.77% | 15.69x | 32.21x | 3.97x | 4.54x | 2.86x | $197.81M | 4.76% | $917.27M | 5.43 | $3.94B | 13.71 | ||
| EXEL | EXELIXIS INC | $44.28 | $36.66 | 20.79% | 15.38x | 13.63x | 5.18x | 5.32x | 0.84x | $875.84M | 7.28% | $2.16B | 7.96 | $11.19B | 11.25 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $770.79 | $456.40 | 68.88% | 17.90x | 16.59x | 5.62x | 2.61x | 1.42x | $4.08B | 5.06% | $31.26B | 298.82 | $81.08B | 13.93 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $480.13 | $192.90 | 148.90% | 31.06x | 23.55x | 10.23x | 6.53x | 1.77x | $3.19B | 2.60% | $18.67B | 73.00 | $118.73B | 24.40 | ||
| UTHR | UNITED THERAPEUTICS CORP | $503.60 | $253.21 | 98.88% | 16.71x | 17.09x | 7.01x | 3.11x | 2.48x | $1.04B | 4.66% | $7.10B | 160.19 | $20.51B | 11.28 | ||
| MDXG | MIMEDX GROUP INC | $4.94 | $2.51 | 97.09% | 14.97x | 44.03x | 1.74x | 2.86x | 3.27x | $72.97M | 10.00% | $256.55M | 1.74 | $585.76M | 7.37 | ||
| INCY | INCYTE CORP | $100.09 | $76.93 | 30.10% | 15.19x | 12.50x | 3.80x | 3.85x | 0.98x | $1.35B | 6.93% | $5.17B | 26.47 | $16.85B | 9.58 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.